Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and ShadowsMaria Chianese, Barbara Ruaro, Liliana Trotta et al.|Pharmaceuticals|2024Cited by 86
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary FibrosisStefano Kette, Barbara Ruaro, Nicolò Reccardini et al.|Pharmaceuticals|2025Cited by 6